@drewfallon12@drewfallon12 Is this a huge positive for Prenetics and IM8 now having 4x and 5.8x revenue multiple on Gruns and Thorne? Why is IM8 not being valued anywhere near fair market value at this point; is just that they aren’t profitable yet
@RomanEcom@TaylorHoliday Without a doubt private markets overvalue companies.
I don’t think IM8 expects to be EBITDA positive until Q4 2027.
But who knows as the company adds 2 new products at the end of this year which aren’t included in the guidance.
That should help order economics.
@RomanEcom@TaylorHoliday Very much agree. They should be at $20 to $25M ARR by end of 2026. Guidance for 2027 was $350m to $400m. AG1 raised at a $1.2b valuation when revenues were around $200m
Last year I started from $0.00 and hit $1,000,000.00 in 105 days.
I also kept track of every single move I made in a daily journal.
Today I'm letting you get access to it. Merry Xmas🥳
Like, RT, and comment "Milly" for the link.
(Must be following)